PHARMA-THUILLIES
0563.416.085 · rovalta.com · 08/11/2026
PHARMA-THUILLIES
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMA-THUILLIES is a Private limited company incorporated in 2014. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Thuin.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0563.416.085
- Incorporation
- 29/09/2014
- Legal form
- Private limited company
- Registered office
- Rue de la Garenne(THL) 7
6536 Thuin · WallonieSee on map - Contributed capital
- 14 500,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 73 k € | +22.4% | 59,6 k € | -38.8% | 97,5 k € | +100% | 48,7 k € | +71.4% | 28,4 k € |
| EBITDA | 71,8 k € | +48.8% | 48,3 k € | -49.9% | 96,2 k € | +101% | 47,8 k € | +72.5% | 27,7 k € |
| Operating result | 71,6 k € | +104% | 35,2 k € | -51.6% | 72,6 k € | +200% | 24,2 k € | +523% | 3,9 k € |
| Net result | 48,3 k € | +101% | 24 k € | -56.4% | 55,1 k € | +170% | 20,4 k € | +26.2% | 16,2 k € |
| Balance sheet | |||||||||
| Equity | 301 k € | +19.1% | 252,7 k € | -0.4% | 253,7 k € | +27.7% | 198,6 k € | +11.4% | 178,2 k € |
| Total assets | 400,6 k € | +20.7% | 332 k € | +6.7% | 311,1 k € | +9.3% | 284,7 k € | -2.8% | 293 k € |
| Cash | 75,3 k € | +34.6% | 56 k € | +51.2% | 37 k € | -10.5% | 41,4 k € | -25.5% | 55,5 k € |
| Debts | 99,6 k € | +25.6% | 79,3 k € | +38.1% | 57,4 k € | -33.3% | 86,1 k € | -25.0% | 114,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thierry VAN WAMBEKE | MandateManager2020 accountsended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/10/2026 | 30/09/2025 | 30/08/2024 | 31/08/2023 | 30/08/2022 | 31/08/2021 |
| General meeting | 27/06/2026 | 28/06/2025 | 29/06/2024 | 24/06/2023 | 25/06/2022 | 26/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 27/06/2026 | 15/10/2026 | French | |
| Micro model | 31/12/2024 | 28/06/2025 | 30/09/2025 | French | |
| Micro model | 31/12/2023 | 29/06/2024 | 30/08/2024 | French | |
| Micro model | 31/12/2022 | 24/06/2023 | 31/08/2023 | French | |
| Micro model | 31/12/2021 | 25/06/2022 | 30/08/2022 | French | |
| Micro model | 31/12/2020 | 26/06/2021 | 31/08/2021 | French | |
| Micro model | 31/12/2019 | 27/06/2020 | 10/09/2020 | French | |
| Micro model | 31/12/2018 | 29/06/2019 | 26/08/2019 | French | |
| Micro model | 31/12/2017 | 30/06/2018 | 25/09/2018 | French | |
| Micro model | 31/12/2016 | 24/06/2017 | 30/08/2017 | French | |
| Abridged model | 31/12/2015 | 25/06/2016 | 15/07/2016 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thierry VAN WAMBEKE | MandateManager2020 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de la Garenne(THL) 7, 6536 ThuilliesCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00561436 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PHARMA-THUILLIESCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00561436 |
Events
- 2025Annual accounts 202548,3 k €↑
- 2024Annual accounts 202424 k €↓
- 2023Annual accounts 202355,1 k €↑
- 2022Annual accounts 202220,4 k €↑
- 2021Annual accounts 202116,2 k €↓
- 2020Annual accounts 202016,3 k €↓
- 2019Annual accounts 201919,2 k €↑
- 2018Annual accounts 20186,5 k €↓
- 2017Annual accounts 201735,2 k €↓
- 2016Annual accounts 201651,5 k €↑
- 2015Annual accounts 201518,8 k €
- 29/09/2014IncorporationPrivate limited company